Obesity and Atrial Fibrillation

Authors

  • J. Tarcísio Medeiros de Vasconcelos

Downloads

Download data is not yet available.

References

Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor, PT. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018;361:1-10. https://doi. org/10.1136/bmj.k145

Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial Fibrillation Begets Atrial Fibrillation. A Study in Awake Chronically Instrumented Goats. Circulation. 1995;92(7):1954-68. https://doi.org/10.1161/01.cir.92.7.1954

Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471-7. https://doi.org/10.1001/jama.292.20.2471

Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29(18):2227-33. https://doi.org/10.1093/eurheartj/ehn324

Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005;19(4):547-66. https://doi.org/10.1016/j.beem.2005.07.009

Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84(3):505-12. https://doi.org/10.1093/ajcn/84.3.505

Kahn SE, Zinman B, Haffner SM, O’Neill MC, Kravitz BG, Yu D, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. 2006;55(8):2357-64. https://doi.org/10.2337/db06-0116

Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109(5):594-600. https://doi.org/10.1161/01.CIR.0000112582.16683.EA

Wildman RP, Farhat GN, Patel AS, Mackey RH, Brockwell S, Thompson T, et al. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension. 2005;45(2):187-92. https://doi.org/10.1161/01.HYP.0000152200.10578.5d

Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565-71. https://doi.org/10.1016/j.jacc.2006.08.060

Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69. https://doi.org/10.1016/j.jacc.2015.03.002

Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R, et al. Prevention and regressive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study. Europace. 2018;20(12):1929-35. https://doi.org/10.1093/europace/euy117

Sivasambu B, Balouch MA, Zghaib T, Bajwa RJ, Chrispin J, Berger RD, et al. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients. J Cardiovasc Electrophysiol. 2018;29(2):239-45. https://doi.org/10.1111/jce.13388

Donnellan E, Wazni O, Kanj M, Hussein A, Baranowski B, Lindsay B, et al. Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric

Published

2020-01-17

How to Cite

Vasconcelos, J. T. M. de. (2020). Obesity and Atrial Fibrillation. JOURNAL OF CARDIAC ARRHYTHMIAS, 32(3), 153–154. Retrieved from https://jca.emnuvens.com.br/jca/article/view/3297

Issue

Section

Editorial